Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer
Mieke Kriege, J.G.M. Klijn(Rotterdam University of Applied Sciences), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Hans Peterse(The Netherlands Cancer Institute), Theo M. de Kok(Erasmus MC Cancer Institute), Harmien M. Zonderland(Leiden University Medical Center), Harry J. de Koning(Erasmus MC), C. Boetes(Radboud University Nijmegen), Emiel J. Rutgers(Oncode Institute), Caroline Seynaeve(Radboud University Nijmegen), Jan C. Oosterwijk(University Medical Center Groningen), Cecile T.M. Brekelmans(Erasmus MC), C.C.M. Bartels(Erasmus MC Cancer Institute), Inge Marie Obdeijn, Madeleine M.A. Tilanus‐Linthorst(Erasmus University Rotterdam), R. A. Manoliu(Amsterdam UMC Location Vrije Universiteit Amsterdam), S. Meijer(Amsterdam UMC Location Vrije Universiteit Amsterdam), A.P.E. Besnard(The Netherlands Cancer Institute), S.H. Muller(The Netherlands Cancer Institute)
Cited by 45
Related Papers
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
|CA A Cancer Journal for Clinicians|2007|2.6k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
|New England Journal of Medicine|2004|1.7k